BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 30928397)

  • 21. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
    Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
    Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overproduction of reactive oxygen species and activation of MAPKs are involved in apoptosis induced by PM2.5 in rat cardiac H9c2 cells.
    Cao J; Qin G; Shi R; Bai F; Yang G; Zhang M; Lv J
    J Appl Toxicol; 2016 Apr; 36(4):609-17. PubMed ID: 26472149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes.
    Tsai CY; Wen SY; Cheng SY; Wang CH; Yang YC; Viswanadha VP; Huang CY; Kuo WW
    J Cell Biochem; 2017 Jul; 118(7):1659-1669. PubMed ID: 27859591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK.
    Li Q; Xiang Y; Chen Y; Tang Y; Zhang Y
    Cell Physiol Biochem; 2017; 44(1):21-37. PubMed ID: 29130959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats.
    Fang IM; Yang CM; Yang CH
    Exp Eye Res; 2015 Jan; 130():38-50. PubMed ID: 25479043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
    Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
    Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
    Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
    Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
    Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Protective Effect of Kirenol against Doxorubicin-Induced Cardiac Hypertrophy in H9c2 Cells through Nrf2 Signaling via PI3K/AKT Pathways.
    Alzahrani AM; Rajendran P; Veeraraghavan VP; Hanieh H
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
    Wu YP; Zhang S; Xin YF; Gu LQ; Xu XZ; Zhang CD; You ZQ
    Phytomedicine; 2021 Jul; 88():153597. PubMed ID: 34111614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
    Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
    J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
    El-Said NT; Mohamed EA; Taha RA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.
    Hajra S; Basu A; Singha Roy S; Patra AR; Bhattacharya S
    Free Radic Res; 2017 Oct; 51(9-10):812-827. PubMed ID: 28922986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
    Ye M; Zhang L; Yan Y; Lin H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.
    Ludke A; Sharma AK; Bagchi AK; Singal PK
    Mol Cell Biochem; 2012 Jan; 360(1-2):215-24. PubMed ID: 21938406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
    Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
    Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
    Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
    Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan oligosaccharides inhibit IL-1β-induced chondrocyte apoptosis via the P38 MAPK signaling pathway.
    Zhang C; Yu L; Zhou Y; Zhao Q; Liu SQ
    Glycoconj J; 2016 Oct; 33(5):735-44. PubMed ID: 27178341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.